Ganciclovir for invasive cytomegalovirus infection in renal allograft recipients.
作者信息
Hrebinko R, Jordan M L, Dummer J S, Hickey D P, Shapiro R, Vivas C, Starzl T E, Simmons R L, Hakala T R
机构信息
Department of Surgery, University of Pittsburgh School of Medicine, Pennsylvania 15213.
出版信息
Transplant Proc. 1991 Feb;23(1 Pt 2):1346-7.
Abstract
摘要
相似文献
1
Ganciclovir for invasive cytomegalovirus infection in renal allograft recipients.更昔洛韦用于肾移植受者的侵袭性巨细胞病毒感染
Transplant Proc. 1991 Feb;23(1 Pt 2):1346-7.
2
Effectiveness of deferred therapy with ganciclovir in renal allograft recipients with cytomegalovirus disease.更昔洛韦延迟治疗对肾移植受者巨细胞病毒病的疗效
Transplant Proc. 1998 Aug;30(5):2083-5. doi: 10.1016/s0041-1345(98)00547-8.
3
Late-acute renal allograft rejection and symptomless cytomegalovirus infection.晚期急性肾移植排斥反应和无症状巨细胞病毒感染。
Lancet. 1994;344(8939-8940):1737-8. doi: 10.1016/s0140-6736(94)92887-8.
4
Cytomegalovirus infection during OKT3 treatment for renal allograft rejection.
Transplant Proc. 1992 Dec;24(6):2634-5.
5
Therapy of cytomegalovirus infections with ganciclovir: a critical appraisal.更昔洛韦治疗巨细胞病毒感染的批判性评价。
Curr Clin Top Infect Dis. 1992;12:309-28.
6
Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.口服更昔洛韦预防肾移植术后患者巨细胞病毒感染的疗效
Clin Transplant. 1997 Dec;11(6):633-9.
7
Therapeutic use of ganciclovir for invasive cytomegalovirus infection in cadaveric renal allograft recipients.更昔洛韦在尸体肾移植受者侵袭性巨细胞病毒感染中的治疗应用。
J Urol. 1992 Nov;148(5):1388-92. doi: 10.1016/s0022-5347(17)36918-5.
8
Ganciclovir treatment of cytomegalovirus infection in heart-lung and double-lung transplant recipients.
Transplant Proc. 1991 Feb;23(1 Pt 2):1174-5.
9
Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis.接受他克莫司、霉酚酸酯和泼尼松并预防使用更昔洛韦的同期肾胰联合移植受者的巨细胞病毒感染模式
Transpl Infect Dis. 2001 Mar;3(1):8-15. doi: 10.1034/j.1399-3062.2001.003001008.x.
10
Ganciclovir therapy for cytomegalovirus disease in liver transplant recipients.
Transplant Proc. 1991 Feb;23(1 Pt 2):1515-6.
引用本文的文献
1
New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.实体器官移植受者巨细胞病毒感染及疾病的预防和治疗新策略。
Clin Microbiol Rev. 2000 Jan;13(1):83-121, table of contents. doi: 10.1128/CMR.13.1.83.
2
Rapid cytomegalovirus pp65 antigenemia assay by direct erythrocyte lysis and immunofluorescence staining.通过直接红细胞裂解和免疫荧光染色进行巨细胞病毒pp65抗原血症快速检测。
J Clin Microbiol. 1998 Mar;36(3):638-40. doi: 10.1128/JCM.36.3.638-640.1998.
3
Infections in solid-organ transplant recipients.实体器官移植受者的感染
Clin Microbiol Rev. 1997 Jan;10(1):86-124. doi: 10.1128/CMR.10.1.86.
本文引用的文献
1
2
Cytomegalovirus as a risk factor in renal transplantation.巨细胞病毒作为肾移植中的一个风险因素。
Transplantation. 1980 Dec;30(6):436-9. doi: 10.1097/00007890-198012000-00010.
3
4
Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies.用9-(1,3-二羟基-2-丙氧甲基)鸟嘌呤治疗艾滋病及其他免疫缺陷患者的严重巨细胞病毒感染。
N Engl J Med. 1986 Mar 27;314(13):801-5. doi: 10.1056/NEJM198603273141301.
5
Ganciclovir therapy for cytomegalovirus disease associated with renal transplants.更昔洛韦治疗肾移植相关的巨细胞病毒疾病
Rev Infect Dis. 1988 Jul-Aug;10 Suppl 3:S554-62. doi: 10.1093/clinids/10.supplement_3.s554.
6
Efficacy of ganciclovir in liver and kidney transplant recipients with severe cytomegalovirus infection.更昔洛韦对严重巨细胞病毒感染的肝肾移植受者的疗效。
Transplantation. 1988 Aug;46(2):229-34. doi: 10.1097/00007890-198808000-00008.
7
Ganciclovir therapy of severe cytomegalovirus infections in solid-organ transplant recipients.更昔洛韦治疗实体器官移植受者的严重巨细胞病毒感染
Transplantation. 1988 Jul;46(1):82-8. doi: 10.1097/00007890-198807000-00015.
8
A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts.一项口服阿昔洛韦预防肾移植受者巨细胞病毒病的随机、安慰剂对照试验。
N Engl J Med. 1989 May 25;320(21):1381-7. doi: 10.1056/NEJM198905253202105.
9
Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation.肾移植后致死性巨细胞病毒感染的临床特征
Surgery. 1977 Nov;82(5):537-46.
Zotero 插件